logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
C

Cancer Immunology Immunotherapy

IF5.1
论文数220
被引数
期刊论文 220
发表时间
delete
Tinostamustine–nivolumab therapy is associated with antigen-specific cellular and humoral immune responses in heavily pre-treated patients with advanced melanoma替诺莫司汀–纳武利尤单抗疗法与高度预治疗晚期黑色素瘤患者的抗原特异性细胞和体液免疫反应相关
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-11-05
delete0
deleteOAAI
deleteShrunal Mane; Vincent Walter; Marie-Therese Abdou; Stefan Diem; Nina Wyss; Kira-Lee Koster; Lenka Besse; Dagmar Hess; Yannis Metaxas; Marie-Claire Flynn; Stefanie Aeppli; Taemer El Saadany; Elke Hiendlmeyer; Roger von Moos; Markus Joerger; Lukas Flatz
delete分享
delete收藏
Tissue-resident memory T cells: resilient sentinels in cancer immunosurveillance and immunotherapy组织驻留记忆T细胞：癌症免疫监视和免疫疗法中的坚韧哨兵
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-11-04
delete0
deleteOAAI
deleteYizhou Yuan; Pengxu Qian; Penglei Jiang
delete分享
delete收藏
Integrated spatial and single-cell profiling reveals prognostic stromal-immune niches within tertiary lymphoid structures of HER2-low breast cancer整合空间与单细胞图谱揭示了HER2低表达乳腺癌三级淋巴结构内的预后基质-免疫微环境
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-11-02
delete0
deleteOAAI
deleteMingzhu Meng; Wen Li; Hongdi Du; Xin Zhou; Rong Fu; Qinghua Gu; Xiaoli Zhou; Yonggang Li
delete分享
delete收藏
Immune and tumor-intrinsic signatures are associated with resistance and response to PD-1 blockade in cutaneous squamous cell carcinoma免疫和肿瘤固有特征与皮肤鳞状细胞癌对PD-1阻断的抵抗和应答相关
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-30
delete0
deleteOAAI
deleteViola K. DeTemple; Maximilian Beikirch; Alina C. Ulama; Moritz Bergmann; Sabine Bredemeier; Vivien Schacht; Michael Sachse; Peter Mohr; Thilo Gambichler; Ralf Gutzmer; Katrin Schaper-Gerhardt
delete分享
delete收藏
Characterization of circulating immune profiles associated with specific COPD phenotypes and concurrent lung cancer status与特定COPD表型和并发肺癌状态相关的循环免疫谱的表征
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-30
delete0
deleteOAAI
deletePaola Ordóñez; María Dolores Miñana; Jaime Signes-Costa; Juan José Soler-Cataluña
delete分享
delete收藏
Phase II study of CIMAvax EGF plus nivolumab in previously treated, immunotherapy-naïve advanced NSCLCCIMAvax EGF联合纳武利尤单抗在先前治疗过、免疫治疗初治的晚期非小细胞肺癌中的II期研究
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-29
delete0
deleteOAAI
deleteRachel Frascati; Andrei Gudkov; Mary E. Reid; Kelvin Lee; Jason B. Muhitch; Circe Mesa; Patricia L. Luaces; Orestes Santos-Morales; Ivan A. Bespalov; Hans Minderman; Joseph D. Tario; Victoria Fitzpatrick; Askia Dozier; Cayla Ford; Xiaojun Liu; Christos Fountzilas; Shipra Gandhi; Kristopher Attwood; Adrienne Groman; Candace Johnson; Zaima Mazorra Herrera; Danay Saavedra; Kalet Leon; Tania Crombet Ramos; Grace K. Dy
delete分享
delete收藏
Tumor-derived TNF-α promotes CCL4⁺ tumor-associated neutrophil formation and immunotherapy resistance in non-small cell lung cancer肿瘤来源的TNF-α促进CCL4⁺肿瘤相关中性粒细胞的形成并诱导非小细胞肺癌的免疫治疗抵抗
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-29
delete0
deleteOAAI
deleteYan Xia; Nan Zhang; Shijin Yuan; Shengjun Wu; Daoyang Zhou
delete分享
delete收藏
Deciphering the macrophage–tumor communication landscape of chemotherapy tolerance in nasopharyngeal carcinoma through single-cell transcriptomics通过单细胞转录组学解析鼻咽癌化疗耐受的巨噬细胞-肿瘤通讯景观
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-28
delete0
deleteOAAI
deleteRan Ding; Mengjie Lei; Meihua Xiao; Qi Quan; Zhiqing Long
delete分享
delete收藏
PD-1 blockade plus gemcitabine and nab-paclitaxel in lymph node-dominant metastatic gallbladder cancer: a real-world study and exploratory single-cell analysisPD-1阻断联合吉西他滨和nab-紫杉醇在淋巴结主导转移性胆囊癌中的应用：一项真实世界研究和探索性单细胞分析
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-27
delete0
deleteOAAI
deleteBing-qian Jiang; Zu-yan Li; Wei Gan; Qiang Zhou; Yu-ning Lin; Kai Kang; Xin-sen Xu; Dong-jie Chen; Ying-bin Liu; Shu-you Peng; Xu-an Wang
delete分享
delete收藏
TIGIT expression induces NKT-like cell hypofunction in hepatocellular carcinoma patients with high HBV loadTIGIT表达诱导高HBV载量肝细胞癌患者NKT样细胞功能低下
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-27
delete0
deleteOAAI
deleteRuoyu Huang; Xu Liu; Xiaojing Yu; Xiaoran Dai; Yuanling Zheng; Meijuan Zheng; Yuanhong Xu; Lu Zong
delete分享
delete收藏
Organ-specific depth of response to CD19-directed CAR T-cell therapy in B-cell lymphomasB细胞淋巴瘤对CD19靶向CAR T细胞疗法的器官特异性应答深度
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-25
delete0
deleteOAAI
deleteMatthias Kassube; Philipp Achhammer; Philipp Linden; Veit L. Bücklein; Tobias Tix; Linus Kruk; Adrien Holzgreve; Rudolf A. Werner; Jens Ricke; Michael von Bergwelt-Baildon; Kai Rejeski; Marion Subklewe; Wolfgang G. Kunz; Michael Winkelmann
delete分享
delete收藏
Adjuvant immune checkpoint inhibitor-based systemic therapies for high-risk renal cell carcinoma after nephrectomy: systematic review and network meta-analysis肾切除术后的高风险肾细胞癌患者使用佐剂免疫检查点抑制剂为基础的系统疗法：系统评价和网络Meta分析
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-23
delete0
deleteOAAI
deleteKeiichiro Miyajima; Kazuma Tsuboi; Keiichiro Mori; Marcin Miszczyk; Felix Lübbersmeyer; Kimia Goodarzi; Deborah Bret; Akihiro Matsukawa; Fumihiko Urabe; Takafumi Yanagisawa; Motoo Araki; Takahiro Kimura; Shahrokh F. Shariat
delete分享
delete收藏
Spatial profiling reveals distinct immune microenvironments in early- vs late-onset colorectal cancer空间分布特征揭示早期与晚期结直肠癌具有不同的免疫微环境
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-22
delete0
deleteOAAI
deleteNiti Jani; Zhongqiu Zhang; Paul Mallory; Hatano Yuichiro; Christopher Flynn; Milind Pore; Masako Nakanishi; Daniel W. Rosenberg
delete分享
delete收藏
A novel IL-13E13Y-based T cell engager, 313TE, promotes anti-tumor function against IL-13Rα2-positive tumor基于IL-13E13Y的新型T细胞接合剂313TE，促进对IL-13Rα2阳性肿瘤的抗肿瘤功能
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-22
delete0
deleteOAAI
deleteLing Tang; Along Ma; Lu Zong; Meijuan Zheng
delete分享
delete收藏
A phase I clinical trial of NK510 combined with PD-1 blockade in patients with advanced non-small cell lung cancerNK510与PD-1阻断联合治疗晚期非小细胞肺癌的I期临床试验
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-20
delete0
deleteOAAI
deleteJing Cheng; Qinpei Cheng; Suhua Zhu; Ying Mei; Fangqing Yang; Ping Zhan; Tianhong Xu; Jun Yan; Xincui Song; Jianya Zhang; Hedong Han; Dongmei Yuan; Yanwen Yao; Tangfeng Lv
delete分享
delete收藏
PRKDC orchestrates immune evasion in hepatocellular carcinoma through CSF1/CSF1R-mediated M2 macrophage polarizationPRKDC通过CSF1/CSF1R介导的M2巨噬细胞极化调控肝细胞癌的免疫逃逸
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-17
delete0
deleteOAAI
deleteYunyong Wang; Wenpeng Pang; Xiaohang Lu; Hemeng Wu; Minpeng Li; Meng Pan; Jinna Tan; Jiaqian He; Yuzhen Luo; Hongsheng Lin; Mingfen Li; Yuan Yu
delete分享
delete收藏
GSDMB synergizes anti-PD-1 efficacy via Sema7a-mediated CD8+ T Cell infiltration in bladder cancerGSDMB通过Sema7a介导的CD8+ T细胞浸润协同增强抗PD-1疗效在膀胱癌中的作用
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-17
delete0
deleteOAAI
deleteYu Shen; Shun Zhang; Shenggen Yu; Kaikai Chen; Jing Li; Zhiwei Chen; Tianyu Ren; Hailong Liu; Ding Xu; Ying Wang; Haibo Shen
delete分享
delete收藏
Distinct high-density neutrophil phenotypes are associated with treatment resistance and immune-related adverse events in lung cancer immunotherapy不同高密度中性粒细胞表型与肺癌免疫治疗中的治疗抵抗和免疫相关不良事件相关
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-15
delete0
deleteOAAI
deleteDa Hyun Kang; Byung-Hee Kang; Pureum Sun; Nayoung Kim; Joo Ho Lee; Jeong Eun Lee
delete分享
delete收藏
B7-H3 promotes triple-negative breast cancer progression by sustaining SP1-dependent HSPA8 expressionB7-H3通过维持SP1依赖性的HSPA8表达促进三阴性乳腺癌进展
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-13
delete0
deleteOAAI
deleteYida Wang; Feng Zhang; Haiyue You; Cenzhu Wang; Zhiwen Qian; Xinfeng Yang; Xin Ning; Ying Jiang; Danping Wu; Lu Liu; Jie Mei; Xiaoqian Zhao; Daozhen Chen; Yan Zhang
delete分享
delete收藏
High-dose vitamin C augments LPS/IFN-γ-induced M1 macrophage polarization through JAK2-STAT1 activation and promotes anti-PD-1 efficacy in pancreatic cancer高剂量维生素C通过JAK2-STAT1激活增强LPS/IFN-γ诱导的M1巨噬细胞极化，并促进胰腺癌中抗PD-1疗效
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-13
delete0
deleteOAAI
deleteHanzheng Zhao; Wentao Fu; Wenyao Zhang; Xiao Li; Tianzhen Zhang; Hongwei Yao; Zhongtao Zhang
delete分享
delete收藏